cerrar
Tagged with Taiwan

MVC’s WHO-Partnered Vaccine a First for Taiwan
As a part of the World Health Organisation’s (WHO) COVID-19 Technology Access Pool (C-TAP), the Medicines Patent Pool has signed a worldwide license…

Diamond Biofund Becomes First VC to List on Taiwan Stock Exchange
In an important milestone for Taiwan's biotech industry, Diamond Biofund – one of the territory's most well-established venture capital (VC) funds…

Taiwan Biotech Listing Snapshot
In just 35 years, Taiwan has gone from having no biotechs on the TAIEX and Taiwan OTC stock exchanges to 124 listed firms with a combined market…

Taiwan Biotech News: Gongwin-KY’s Lung Cancer Approval,…
The latest pharma news from Taiwan, including Gongwin-KY's lung cancer drug approval in China, Anxo Pharmaceutical/Genovior Biotech alliance, Taiwan's…

Taiwan Pharma Market Snapshot
With a healthcare system that is emerging as one of the most advanced in Asia and legislation that aims to support the biomedical industry, Taiwan’s…

Real-World Evidence Regulatory Landscape in Asia Pacific
Writing in the June edition of DIA’s Global Forum magazine, Ellen Sem, Fengyun (Vicky) Han and Annetta C. Beauregard from Janssen Pharmaceutical…

Taiwan Healthcare and Pharma News
The latest healthcare and pharma news from Taiwan, including the CDMO Bora Pharmaceutical's acquisition of Eden Biologics assets, the FDA fast track…

China Pharma News: BioNTech-Fosun JV; Patent Law Revamp; Hong…
The latest news from Chinese pharma, including an overhaul of the country’s patent law; a BioNTech-Fosun tie-up on COVID-19 vaccines; and big…

Steve Profit – General Manager, Novo Nordisk Taiwan
Novo Nordisk's Steve Profit outlines the progression of the group's strategy in Taiwan, how the affiliate works with the Taiwanese healthcare system…

Medigen’s Charles Chen on Cell Culture Vaccine Strategies
Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s COVID-19 vaccine strategy, and what…

Charles Chen – Vice Chairman & CEO, Medigen Vaccine…
Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company's COVID-19 vaccine strategy, and what…

Andrew Hexter – Vice President & General Manager Asia…
Andrew Hexter, VP and GM of Gilead Asia 5 (Hong Kong, Singapore, South Korea, Taiwan and Malaysia), shares the highlights of his past three years…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here